AssetID: 55248501
Headline: Trump Strikes Deal to Cut Weight-Loss Drug Prices
Caption: President Trump has unveiled new agreements with Eli Lilly and Novo Nordisk to lower the cost of weight-loss drugs such as Wegovy and Zepbound. The deals will expand access through Medicare and Medicaid, introduce discounted prices on the upcoming TrumpRx website, and mark a major step in the administration's push to make prescription drugs more affordable.
Keywords: Current Affairs & Politics,Donald Trump,weight-loss drugs,Eli Lilly,Novo Nordisk,Wegovy,Zepbound,GLP-1 drugs,TrumpRx,Medicare,Medicaid,drug pricing,obesity treatment,orforglipron,Mounjaro,Ozempic,prescription discounts,pharmaceutical deals,Robert F. Kennedy Jr.,Pfizer,AstraZeneca,EMD Serono,FDA approval,healthcare affordability,U.S. government,obesity policy
PersonInImage: